Filing Details
- Accession Number:
- 0001179110-17-011728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-22 17:37:00
- Reporting Period:
- 2017-08-20
- Accepted Time:
- 2017-08-22 16:37:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Innoviva Inc. | INVA | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1622268 | Eric Desparbes | 2000 Sierra Point Parkway Suite 500 Brisbane CA 94005 | Svp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-08-20 | 5,770 | $12.28 | 344,993 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-08-21 | 1,825 | $12.20 | 343,168 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were withheld by the Company to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.
- This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.